Senate Democrats See ‘Major Progress' on Biden's Economic Agenda Bill

Schumer and Manchin are close to a deal on prescription drug savings, new details obtained by NBC News show. They're also negotiating energy and tax provisions in the bill.

Senate Majority Leader Chuck Schumer, D-N.Y.,
AP Photo/J. Scott Applewhite, File

WASHINGTON — Senate Democrats are close to a deal to lower prescription drug costs as part of a larger party-line package to advance a number of President Joe Biden's economic priorities, three sources familiar with the negotiations told NBC News.

Democrats plan to submit a "finalized agreement" on allowing Medicare to negotiate prices with pharmaceutical companies to a key Senate official "in the coming days" to see if it complies with the chamber's strict budget rules, one of the sources said.



Watch NBC10 Boston news for free, 24/7, wherever you are.


Get Boston local news, weather forecasts, lifestyle and entertainment stories to your inbox. Sign up for NBC Boston’s newsletters.

The source, who requested anonymity to discuss sensitive negotiations between Senate Majority Leader Chuck Schumer, D-N.Y., and Sen. Joe Manchin, D-W.Va, described the expected move as "major progress" that shows Democratic leadership wants to "move forward with a bill on the floor as early as next month."

CVS Health, Rite Aid and Amazon announced Tuesday that they were limiting orders of emergency contraceptive pills to three per order in an effort to ensure “equitable access and consistent supply on store shelves.”

There's no final deal on the broader bill, however, as the other major parts of the "reconciliation" package — energy and climate policy provisions and tax changes to raise revenue — are still being negotiated between Schumer and Manchin. Unless an agreement can be reached quickly, it would be difficult to pass the bill before a scheduled month-long August recess.

The West Virginia Democrat’s office said Wednesday there is consensus and a path forward on drug pricing.

Read the full story at

Contact Us